Cantor Fitzgerald, L. P. Oric Pharmaceuticals, Inc. Transaction History
Cantor Fitzgerald, L. P.
- $4.65 Billion
- Q1 2025
A detailed history of Cantor Fitzgerald, L. P. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 200,000 shares of ORIC stock, worth $2.31 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
200,000
Previous 22,704
780.9%
Holding current value
$2.31 Million
Previous $183,000
509.84%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ORIC
# of Institutions
145Shares Held
75.9MCall Options Held
11.3KPut Options Held
2.7K-
Viking Global Investors LP6.57MShares$75.9 Million0.12% of portfolio
-
Nextech Invest Ag5.29MShares$61 Million7.95% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.29MShares$61 Million6.85% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$55.8 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY4MShares$46.2 Million0.05% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $457M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...